LIN54_HUMAN - dbPTM
LIN54_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID LIN54_HUMAN
UniProt AC Q6MZP7
Protein Name Protein lin-54 homolog
Gene Name LIN54
Organism Homo sapiens (Human).
Sequence Length 749
Subcellular Localization Nucleus .
Protein Description Component of the DREAM complex, a multiprotein complex that can both act as a transcription activator or repressor depending on the context. [PubMed: 17671431]
Protein Sequence MEVVPAEVNSLLPEEIMDTGITLVDDDSIEAVIVSSPIPMETELEEIVNINSTGDSTATPISTEPITVYSNHTNQVAVNTTITKADSNTTVKPAFPSGLQKLGAQTPVTISANQIILNKVSQTSDLKLGNQTLKPDGQKLILTTLGKSGSPIVLALPHSQLPQAQKVTTQAQSGDAKLPPQQIKVVTIGGRPEVKPVIGVSALTPGSQLINTTTQPSVLQTQQLKTVQIAKKPRTPTSGPVITKLIFAKPINSKAVTGQTTQVSPPVIAGRVLSQSTPGTPSKTITISESGVIGSTLNSTTQTPNKIAISPLKSPNKAVKSTVQTITVGGVSTSQFKTIIPLATAPNVQQIQVPGSKFHYVRLVTATSASSSTQPVSQNPSTNTQPLQQAKPVVVNTTPVRMSVPIVSAQAVKQVVPKPINPTSQIVTTSQPQQRLIMPATPLPQIQPNLTNLPPGTVLAPAPGTGNVGYAVLPAQYVTQLQQSSYVSIASNSTFTGTSGIQTQARLPFNGIIPSESASRPRKPCNCTKSLCLKLYCDCFANGEFCNNCNCTNCYNNLEHENERQKAIKACLDRNPEAFKPKIGKGKEGESDRRHSKGCNCKRSGCLKNYCECYEAKIMCSSICKCIGCKNFEESPERKTLMHLADAAEVRVQQQTAAKTKLSSQISDLLTRPTPALNSGGGKLPFTFVTKEVAEATCNCLLAQAEQADKKGKSKAAAERMILEEFGRCLMSVINSAGKAKSDPCAMNC
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
11 (in isoform 3)Ubiquitination-8.57-
14 (in isoform 3)Phosphorylation-61.1925159151
16 (in isoform 3)Phosphorylation-2.6325627689
23AcetylationIMDTGITLVDDDSIE
HHHCCCEEECCCCCE
3.6219608861
28AcetylationITLVDDDSIEAVIVS
CEEECCCCCEEEEEC
29.3519608861
35PhosphorylationSIEAVIVSSPIPMET
CCEEEEECCCCCCCC
21.1926074081
36PhosphorylationIEAVIVSSPIPMETE
CEEEEECCCCCCCCC
18.8926074081
42PhosphorylationSSPIPMETELEEIVN
CCCCCCCCCHHHHHC
39.3526074081
92AcetylationADSNTTVKPAFPSGL
CCCCCCCCCCCCCHH
28.6523954790
92UbiquitinationADSNTTVKPAFPSGL
CCCCCCCCCCCCCHH
28.65-
101UbiquitinationAFPSGLQKLGAQTPV
CCCCHHHHCCCCCCE
54.66-
106PhosphorylationLQKLGAQTPVTISAN
HHHCCCCCCEEEECC
21.1325159151
106O-linked_GlycosylationLQKLGAQTPVTISAN
HHHCCCCCCEEEECC
21.1320068230
109O-linked_GlycosylationLGAQTPVTISANQII
CCCCCCEEEECCHHH
15.4920068230
109PhosphorylationLGAQTPVTISANQII
CCCCCCEEEECCHHH
15.4927174698
111O-linked_GlycosylationAQTPVTISANQIILN
CCCCEEEECCHHHHH
16.2920068230
111PhosphorylationAQTPVTISANQIILN
CCCCEEEECCHHHHH
16.2927174698
119UbiquitinationANQIILNKVSQTSDL
CCHHHHHCCCCCCCC
39.56-
121PhosphorylationQIILNKVSQTSDLKL
HHHHHCCCCCCCCCC
29.3827174698
123PhosphorylationILNKVSQTSDLKLGN
HHHCCCCCCCCCCCC
19.3927174698
124PhosphorylationLNKVSQTSDLKLGNQ
HHCCCCCCCCCCCCE
33.0527174698
127UbiquitinationVSQTSDLKLGNQTLK
CCCCCCCCCCCEEEC
60.38-
134UbiquitinationKLGNQTLKPDGQKLI
CCCCEEECCCCCEEE
44.44-
134AcetylationKLGNQTLKPDGQKLI
CCCCEEECCCCCEEE
44.4426051181
136AcetylationGNQTLKPDGQKLILT
CCEEECCCCCEEEEE
71.2519608861
136UbiquitinationGNQTLKPDGQKLILT
CCEEECCCCCEEEEE
71.2519608861
139UbiquitinationTLKPDGQKLILTTLG
EECCCCCEEEEEECC
42.92-
139SumoylationTLKPDGQKLILTTLG
EECCCCCEEEEEECC
42.9228112733
143PhosphorylationDGQKLILTTLGKSGS
CCCEEEEEECCCCCC
17.0025954137
144PhosphorylationGQKLILTTLGKSGSP
CCEEEEEECCCCCCC
30.0225954137
147UbiquitinationLILTTLGKSGSPIVL
EEEEECCCCCCCEEE
55.55-
147AcetylationLILTTLGKSGSPIVL
EEEEECCCCCCCEEE
55.5525953088
148PhosphorylationILTTLGKSGSPIVLA
EEEECCCCCCCEEEE
42.5824732914
150PhosphorylationTTLGKSGSPIVLALP
EECCCCCCCEEEEEC
20.6725159151
159PhosphorylationIVLALPHSQLPQAQK
EEEEECHHHCCCCCC
31.3225954137
166UbiquitinationSQLPQAQKVTTQAQS
HHCCCCCCCCCCCCC
44.56-
168O-linked_GlycosylationLPQAQKVTTQAQSGD
CCCCCCCCCCCCCCC
21.8920068230
195UbiquitinationIGGRPEVKPVIGVSA
ECCCCCCCCEEEEEE
31.72-
195AcetylationIGGRPEVKPVIGVSA
ECCCCCCCCEEEEEE
31.7226051181
235PhosphorylationQIAKKPRTPTSGPVI
EECCCCCCCCCCCCE
39.1726657352
235O-linked_GlycosylationQIAKKPRTPTSGPVI
EECCCCCCCCCCCCE
39.1720068230
237PhosphorylationAKKPRTPTSGPVITK
CCCCCCCCCCCCEEE
45.7828450419
237O-linked_GlycosylationAKKPRTPTSGPVITK
CCCCCCCCCCCCEEE
45.7820068230
238O-linked_GlycosylationKKPRTPTSGPVITKL
CCCCCCCCCCCEEEE
42.1632574038
238PhosphorylationKKPRTPTSGPVITKL
CCCCCCCCCCCEEEE
42.1628450419
238O-linked_GlycosylationKKPRTPTSGPVITKL
CCCCCCCCCCCEEEE
42.1620068230
243PhosphorylationPTSGPVITKLIFAKP
CCCCCCEEEEEEEEE
21.7428450419
243O-linked_GlycosylationPTSGPVITKLIFAKP
CCCCCCEEEEEEEEE
21.7420068230
244AcetylationTSGPVITKLIFAKPI
CCCCCEEEEEEEEEC
28.5819608861
249AcetylationITKLIFAKPINSKAV
EEEEEEEEECCCCCC
35.3619608861
249UbiquitinationITKLIFAKPINSKAV
EEEEEEEEECCCCCC
35.3619608861
253O-linked_GlycosylationIFAKPINSKAVTGQT
EEEEECCCCCCCCCC
23.7820068230
254UbiquitinationFAKPINSKAVTGQTT
EEEECCCCCCCCCCC
42.25-
257PhosphorylationPINSKAVTGQTTQVS
ECCCCCCCCCCCCCC
28.5624732914
260PhosphorylationSKAVTGQTTQVSPPV
CCCCCCCCCCCCCCE
22.1224732914
261PhosphorylationKAVTGQTTQVSPPVI
CCCCCCCCCCCCCEE
21.0530266825
264PhosphorylationTGQTTQVSPPVIAGR
CCCCCCCCCCEEECE
17.4223401153
268AcetylationTQVSPPVIAGRVLSQ
CCCCCCEEECEEECC
4.0819608861
268UbiquitinationTQVSPPVIAGRVLSQ
CCCCCCEEECEEECC
4.0819608861
274PhosphorylationVIAGRVLSQSTPGTP
EEECEEECCCCCCCC
21.1630266825
276PhosphorylationAGRVLSQSTPGTPSK
ECEEECCCCCCCCCC
32.9430266825
276O-linked_GlycosylationAGRVLSQSTPGTPSK
ECEEECCCCCCCCCC
32.9420068230
277PhosphorylationGRVLSQSTPGTPSKT
CEEECCCCCCCCCCE
20.3530266825
280PhosphorylationLSQSTPGTPSKTITI
ECCCCCCCCCCEEEE
26.1230266825
282PhosphorylationQSTPGTPSKTITISE
CCCCCCCCCEEEEEC
42.1230266825
282O-linked_GlycosylationQSTPGTPSKTITISE
CCCCCCCCCEEEEEC
42.1220068230
283AcetylationSTPGTPSKTITISES
CCCCCCCCEEEEECC
45.1926051181
288O-linked_GlycosylationPSKTITISESGVIGS
CCCEEEEECCCCCCC
19.6320068230
290O-linked_GlycosylationKTITISESGVIGSTL
CEEEEECCCCCCCCC
31.4120068230
295PhosphorylationSESGVIGSTLNSTTQ
ECCCCCCCCCCCCCC
20.7127080861
296O-linked_GlycosylationESGVIGSTLNSTTQT
CCCCCCCCCCCCCCC
25.4220068230
296PhosphorylationESGVIGSTLNSTTQT
CCCCCCCCCCCCCCC
25.4227080861
299PhosphorylationVIGSTLNSTTQTPNK
CCCCCCCCCCCCCCE
35.6227251275
300PhosphorylationIGSTLNSTTQTPNKI
CCCCCCCCCCCCCEE
23.1127080861
301PhosphorylationGSTLNSTTQTPNKIA
CCCCCCCCCCCCEEE
30.2127080861
303PhosphorylationTLNSTTQTPNKIAIS
CCCCCCCCCCEEEEC
27.0827080861
310PhosphorylationTPNKIAISPLKSPNK
CCCEEEECCCCCCCH
18.3729255136
313UbiquitinationKIAISPLKSPNKAVK
EEEECCCCCCCHHHH
68.22-
314PhosphorylationIAISPLKSPNKAVKS
EEECCCCCCCHHHHC
41.1929255136
321O-linked_GlycosylationSPNKAVKSTVQTITV
CCCHHHHCCCEEEEE
27.4920068230
321PhosphorylationSPNKAVKSTVQTITV
CCCHHHHCCCEEEEE
27.4925332170
332O-linked_GlycosylationTITVGGVSTSQFKTI
EEEECCCCHHHCEEE
26.1420068230
333O-linked_GlycosylationITVGGVSTSQFKTII
EEECCCCHHHCEEEE
24.9220068230
333PhosphorylationITVGGVSTSQFKTII
EEECCCCHHHCEEEE
24.9225332170
344O-linked_GlycosylationKTIIPLATAPNVQQI
EEEEEECCCCCEEEE
50.7820068230
344PhosphorylationKTIIPLATAPNVQQI
EEEEEECCCCCEEEE
50.7825332170
357AcetylationQIQVPGSKFHYVRLV
EEECCCCCEEEEEEE
41.9219608861
357UbiquitinationQIQVPGSKFHYVRLV
EEECCCCCEEEEEEE
41.9219608861
357SumoylationQIQVPGSKFHYVRLV
EEECCCCCEEEEEEE
41.9228112733
371PhosphorylationVTATSASSSTQPVSQ
EEEECCCCCCCCCCC
36.80-
397PhosphorylationAKPVVVNTTPVRMSV
CCCEEEECCCCCCCC
22.3727732954
398PhosphorylationKPVVVNTTPVRMSVP
CCEEEECCCCCCCCC
18.0025159151
413UbiquitinationIVSAQAVKQVVPKPI
EEEHHHHHCCCCCCC
40.15-
418UbiquitinationAVKQVVPKPINPTSQ
HHHCCCCCCCCCCCC
47.09-
418AcetylationAVKQVVPKPINPTSQ
HHHCCCCCCCCCCCC
47.0926051181
429O-linked_GlycosylationPTSQIVTTSQPQQRL
CCCCEEECCCCCCEE
17.9220068230
430O-linked_GlycosylationTSQIVTTSQPQQRLI
CCCEEECCCCCCEEE
30.4220068230
430PhosphorylationTSQIVTTSQPQQRLI
CCCEEECCCCCCEEE
30.4226714015
435MethylationTTSQPQQRLIMPATP
ECCCCCCEEECCCCC
22.42-
515PhosphorylationPFNGIIPSESASRPR
CCCCCCCCCCCCCCC
33.5028555341
529UbiquitinationRKPCNCTKSLCLKLY
CCCCCCCHHHHHHHH
43.56-
569UbiquitinationNERQKAIKACLDRNP
HHHHHHHHHHHHCCH
37.60-
580UbiquitinationDRNPEAFKPKIGKGK
HCCHHHHCCCCCCCC
53.07-
580AcetylationDRNPEAFKPKIGKGK
HCCHHHHCCCCCCCC
53.0726051181
582UbiquitinationNPEAFKPKIGKGKEG
CHHHHCCCCCCCCCC
65.76-
608UbiquitinationCKRSGCLKNYCECYE
CCCCCCCHHHHHHHH
50.36-
635PhosphorylationGCKNFEESPERKTLM
CCCCCCCCCCHHHHH
25.5123401153
639SumoylationFEESPERKTLMHLAD
CCCCCCHHHHHHHHH
44.33-
639SumoylationFEESPERKTLMHLAD
CCCCCCHHHHHHHHH
44.3328112733
639UbiquitinationFEESPERKTLMHLAD
CCCCCCHHHHHHHHH
44.33-
640PhosphorylationEESPERKTLMHLADA
CCCCCHHHHHHHHHH
35.2224719451
659SumoylationVQQQTAAKTKLSSQI
HHHHHHHHHHHHHHH
43.6728112733
661SumoylationQQTAAKTKLSSQISD
HHHHHHHHHHHHHHH
45.74-
661SumoylationQQTAAKTKLSSQISD
HHHHHHHHHHHHHHH
45.7428112733
661UbiquitinationQQTAAKTKLSSQISD
HHHHHHHHHHHHHHH
45.74-
661AcetylationQQTAAKTKLSSQISD
HHHHHHHHHHHHHHH
45.7425953088
663PhosphorylationTAAKTKLSSQISDLL
HHHHHHHHHHHHHHH
23.0426714015
664PhosphorylationAAKTKLSSQISDLLT
HHHHHHHHHHHHHHH
41.8026714015
667PhosphorylationTKLSSQISDLLTRPT
HHHHHHHHHHHHCCC
17.9928555341
671PhosphorylationSQISDLLTRPTPALN
HHHHHHHHCCCCCCC
41.7326714015
683UbiquitinationALNSGGGKLPFTFVT
CCCCCCCCCCEEEEC
57.15-
683AcetylationALNSGGGKLPFTFVT
CCCCCCCCCCEEEEC
57.1526051181
710UbiquitinationAQAEQADKKGKSKAA
HHHHHHCCCCCCHHH
67.45-
711UbiquitinationQAEQADKKGKSKAAA
HHHHHCCCCCCHHHH
72.60-
715AcetylationADKKGKSKAAAERMI
HCCCCCCHHHHHHHH
45.607365103
741SumoylationINSAGKAKSDPCAMN
HHHCCCCCCCCCCCC
59.90-
741SumoylationINSAGKAKSDPCAMN
HHHCCCCCCCCCCCC
59.90-
741UbiquitinationINSAGKAKSDPCAMN
HHHCCCCCCCCCCCC
59.90-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of LIN54_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of LIN54_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of LIN54_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
LIN9_HUMANLIN9physical
17531812
LIN37_HUMANLIN37physical
17531812
LIN52_HUMANLIN52physical
17531812
MYBB_HUMANMYBL2physical
17531812
E2F4_HUMANE2F4physical
17531812
RBL2_HUMANRBL2physical
17531812
TFDP1_HUMANTFDP1physical
17531812
TFDP2_HUMANTFDP2physical
17531812
RBBP4_HUMANRBBP4physical
17531812
MYBA_HUMANMYBL1physical
17531812
LIN9_HUMANLIN9physical
17671431
LIN37_HUMANLIN37physical
17671431
MYBB_HUMANMYBL2physical
17671431
RBBP4_HUMANRBBP4physical
17671431
RBL2_HUMANRBL2physical
17671431
RBL1_HUMANRBL1physical
17671431
E2F4_HUMANE2F4physical
17671431
RBL2_HUMANRBL2physical
19725879
MYBB_HUMANMYBL2physical
19725879
MYBB_HUMANMYBL2physical
25368258

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of LIN54_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-244; LYS-249 AND LYS-357,AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-282, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-310 AND SER-314, ANDMASS SPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-310 AND SER-314, ANDMASS SPECTROMETRY.

TOP